GPX4, an enzyme that is inactivated by GSH depletion [7] . In addition, p53 inhibits cystine uptake and promotes ROS-induced stress by repressing the key system x c -component, SLC7A11, suggesting a novel anti-cancer mechanism of this tumor suppressor gene [8] . Sorafenib, a multikinase inhibitor and effective anti-tumor drug, was found to have cytotoxic effects on the hepatocellular carcinoma (HCC) cells through triggering the iron-dependent oxidative cell death, ferroptosis. And this form of cell death is enhanced in retinoblastoma (Rb) proteinnegative HCC cells [9] . Thus, blocking the activities of antioxidase, system x c -, GSH synthetise, and GPX4, or increasing the concentration of iron would induce extremely aberrant ROS production and lipid peroxidation, the high-risk factors for inducing ferroptosis [1] . Accordingly, a series of ferroptosis inducers and inhibitors have been developed and tested (Table 1) [1, 5, [10] [11] [12] . These are useful tools for further study of the specific mechanism and process of ferroptosis.
Considering that the change of mitochondria was the major morphology difference in those multiple types of cell death and that GPX4, an essential ferroptosis regulator gene with the six mitochondria genes exhibiting abnormal expression during ferroptosis [5] , locates in mitochondrion [7] , we believe that mitochondria may play a central role in ferroptosis. Some researchers have showed that mitochondrial oxidation is not the lethal factor for ferroptosis, and the outer mitochondrial membrane rupture just represents the irreversible ferroptosis [1, 5] . How does the contradiction emerge? The crucial target for oxidation is still unknown at present. Besides mitochondria, other sites of ROS production and accumulation may also be important for ferroptosis. During ferroptosis, the endoplasmic reticulum (ER) and attached ribosome may be the first damaged sites which then transmit the damage signal to the mitochondria. Just as in photodynamic stress therapy, the initial ROS stimulate reticulophagy by impairing ER, and this oxidative damage is rapidly conveyed to the mitochondria and causes cell death [13] . ROS, as important signaling molecules, are involved in multiple pathologic processes, such as autophagy. Whether the compensatory action autophagy can be arisen to remove ferroptosis injured cells? How does this cross-talk occur? These are important questions to be answered in the future.
Iron overload can induce ROS production, oxidation of the lipid, protein and DNA, and trigger or mediate cell death. However, the cell death patterns have not been particularly explored. The discovery of ferroptosis partially elucidates the iron-related cell death. Ferroptosis can be prevented by treatment with iron chelator or interference with iron metabolism regulator, such as iron response element binding protein 2 (IREB2) [5] . Thus, iron metabolism-related proteins are crucial for the study of ferroptosis. Previous studies have indicated that both iron deficiency and iron overload are harmful to human health. High ferrous in the heart is easy to cause myocardial dysfunction and metabolism injury, and eventually lead to heart disease [14, 15] . Iron overload is closely related to many metabolism diseases because it can stimulate lipid oxidation and tissue damage, leading to atherosclerosis and diabetes. Abnormal iron accumulation is often found in tumor and neuronal diseases, which are prone to induce ferroptosis. So, further studies are needed to clearify whether ferroptosis plays a role in these iron deposition-related diseases and whether it can serve as a therapeutic target?
In brief, the discovery of the ferroptosis in normal cells is a great progress in the research of cell death. Lipid hydroperoxides are described as the driving force and iron as the catalyst for ferroptosis. Thus, identifying the ROS target sites and understanding the detailed mechanism of lipid oxidation and iron action will be beneficial to the treatment of iron overload-related diseases, such as atherosclerosis, cardiovascular diseases, and diabetes by targeted ferroptosis interference.
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